Santhiago, M R <br/><br/>
Monocyte development inhibitor PRM-151 decreases corneal myofibroblast generation in rabbits.  [electronic resource] 

 -  Experimental eye research  Nov 2011 
 - 786-9 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0007 
<br/><br/><label>Standard No.: </label>10.1016/j.exer.2011.08.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--metabolism<br/>Animals<br/>Cell Count<br/>Cell Differentiation--drug effects<br/>Corneal Injuries<br/>Corneal Opacity--metabolism<br/>Corneal Stroma--drug effects<br/>Female<br/>Fluorescent Antibody Technique, Indirect<br/>Homeodomain Proteins--administration & dosage<br/>Injections, Intraocular<br/>Lasers, Excimer<br/>Monocytes--drug effects<br/>Myofibroblasts--metabolism<br/>Myopia--surgery<br/>Photorefractive Keratectomy<br/>Rabbits<br/>Recombinant Proteins--administration & dosage<br/>Serum Amyloid P-Component--administration & dosage